NASDAQ · Drug Manufacturers - Specialty & Generic
Organogenesis Holdings Inc (ORGO)
$0.77
-6.20%
16
Oversold
Moving averages
SMA 200$2.63-70.79%
Company profile
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures and markets solutions for the advanced wound care and surgical and sports medicine markets in the United States. The company is headquartered in Canton, Massachusetts.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$158.27M
P/E ratioNone
EPS$-0.83
Beta1.269
Dividend yield0.00%
52-week high$7.08
52-week low$1.20
Similar stocks in Drug Manufacturers - Specialty & Generic
RSI alerts for ORGO
An email when ORGO closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 9:48 PM EDT